Mayo Clinic Laboratories’ updated approach to fluorescence in situ hybridization (FISH) testing was designed to simplify the ordering process and provide appropriate testing to meet individual patient needs. Testing options for adult and pediatric patients are now available by disease state, including only the most relevant genetic probes, while specified panels continue to provide flexibility to select probe offerings.